Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • INSM vs GSK✓SelectedUSD · GSKINSM vs GSK performance historyLatest closeAs of+20.58%11/19
Stock and ETF performance explorer

INSM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-12.4%
GSK return
+175.7%
Excess return
-188.2%
Maximum drawdown
-98.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+20.6%-1.6%+22.1%+21.2%
7D+22.4%-4.7%+27.1%+24.7%
30D+51.0%-4.7%+55.7%+53.7%
3M+10.6%-8.8%+19.3%+14.5%
6M+34.5%-4.6%+39.1%+36.7%
YTD-17.0%+1.0%-18.0%-18.0%
1Y-29.0%+6.9%-35.9%-31.6%
3Y+482.0%+52.5%+429.5%+365.5%
5Y+374.3%+40.3%+334.0%+287.3%
10Y+884.1%+99.0%+785.1%+596.6%
All-12.4%+175.7%-188.2%-44.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling